A Quick Options Activity Update
Wednesday, June 02, 2010



Amgen (AMGN)

Among the stocks to watch, Amgen (AMGN) is trading up 4.4 percent after the FDA approved Prolia, a treatment for osteoporosis.



Monsanto (MON)

Monsanto (MON) rose more than 4 percent after being added to the Conviction Buy List at Goldman Sachs.





SPECIAL DISCOUNTED MEMBERSHIP RATES UNTIL JUNE 30, 2010






Search Stock Options
Made Easy





FREE E-ZINE
"SUCCESS WITH STOCK OPTIONS TRADING"

magazine cover for S.O.M.E.


Email

Name

Your e-mail address is secure and will never be shared.

GET FREE
SUBSCRIPTION NOW!






new

OPTION TRADES FOR $39.00/MONTH
Click here TO FIND OUT MORE INFORMATION



Follow S_O_M_E on Twitter